Clinical Trials Directory

Trials / Completed

CompletedNCT01082458

Comparison of Lidocaine and Remifentanil for the Effect on Responses to the Endotracheal Tube During Emergence From General Anesthesia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
67 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
Female
Age
20 Years
Healthy volunteers
Not accepted

Summary

Target concentration infusion(TCI) of remifentanil (2.0ng/ml) suppresses the cough induced by endotracheal tube more effectively than intravenous administration of lidocaine (1.5mg/kg).

Conditions

Interventions

TypeNameDescription
DRUGremifentanil / lidocaineRemifentanil TCI group : target controlled infusion of 2.0ng/ml of remifentanil on end of surgery. Lidocaine IV group : Intravenous administration of 1.5mg/kg of lidocaine on end of surgery.

Timeline

Start date
2010-02-01
Primary completion
2010-07-01
Completion
2010-07-01
First posted
2010-03-08
Last updated
2010-11-19

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01082458. Inclusion in this directory is not an endorsement.

Comparison of Lidocaine and Remifentanil for the Effect on Responses to the Endotracheal Tube During Emergence From Gene (NCT01082458) · Clinical Trials Directory